Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
16.46
+0.86 (5.51%)
Apr 1, 2025, 2:45 PM CST
SHA:600521 Revenue
Zhejiang Huahai Pharmaceutical had revenue of 2.12B CNY in the quarter ending September 30, 2024, with 10.76% growth. This brings the company's revenue in the last twelve months to 9.35B, up 8.26% year-over-year. In the year 2023, Zhejiang Huahai Pharmaceutical had annual revenue of 8.31B with 0.52% growth.
Revenue (ttm)
9.35B
Revenue Growth
+8.26%
P/S Ratio
2.57
Revenue / Employee
1.14M
Employees
8,221
Market Cap
23.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.31B | 42.97M | 0.52% |
Dec 31, 2022 | 8.27B | 1.62B | 24.42% |
Dec 31, 2021 | 6.64B | 158.36M | 2.44% |
Dec 31, 2020 | 6.49B | 1.10B | 20.36% |
Dec 31, 2019 | 5.39B | 293.50M | 5.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |